
    
      A two-phase, single center, study of 20 subjects to assess 4 weeks of add-on therapy of
      Topicort® BID and 12 weeks BID on two consecutive days a week to patients with ≤5% BSA who
      are receiving biologic therapy for at least 24 weeks.

      Adult male and female subjects with moderate to severe chronic plaque psoriasis All patients
      will receive Topicort® BID for 4 weeks.

      After week 4 patients will receive Topicort® BID on two consecutive days a week for 12 weeks.
    
  